** Shares of India's Cohance Lifesciences COHA.NS fall as much as ~8.6% to 443 rupees
** The pharmaceutical company's quarterly profit down ~83.8% y/y to 195.5 million rupees ($2.04 million), pressured by lower sales, higher costs
** Revenue from operations down ~26.3% y/y
** Jefferies downgrades COHA rating to "underperform" from "hold", cuts PT by 40 rupees to 300 rupees
** Trims FY27-FY28 EPS estimates by 14%-17%, citing near-term growth challenges and margin pressure from higher costs
** YTD, COHA stock down ~13%
($1 = 95.6300 Indian rupees)
(Reporting by Bipasha Dey in Bengaluru)
((Bipasha.Dey@thomsonreuters.com;))